Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niederle

Showing results (131-140 of 490) with videos related to

Pageof 49
Sort By:
Gland Surgery|July 17, 2025
<i>RET</i> Y791F in MEN2: a variant presumed non-pathogenic, yet lacking conclusive evidence of insignificanceTeresa Binter, Martin Bruno Niederle, Melisa Arikan, et al.
International Journal of Cell Cloning|September 1, 1992
Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemiaU B Wandl, N Niederle, M Kranzhoff, et al.
Deutsche Medizinische Wochenschrift (1946)|December 25, 1981
[Individualized interval shortening in the chemotherapeutic induction treatment of solid tumors (author's transl)]S Seeber, M Higi, N Niederle, et al.
Wiener Klinische Wochenschrift|November 3, 2004
[Imaging of tumours of the adrenal gland]Gertraud Heinz-Peer, Brigitte Happel, Gerhard Prager, et al.
Wiener Klinische Wochenschrift|January 1, 1993
[Diabetes mellitus and carbohydrate metabolism in primary hyperparathyroidism]A Kautzky-Willer, B Niederle, G Schernthaner, et al.
Klinische Wochenschrift|July 15, 1987
[Detection of nephrotoxicity of human alpha 2b interferon with special reference to the analysis of urine enzymes in patients with chronic myeloid leukemia]E Kurschel, U Metz-Kurschel, W Hofmann, et al.
Cancers|February 10, 2024
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?Teresa Binter, Sabina Baumgartner-Parzer, Marie Helene Schernthaner-Reiter, et al.
Wiener Klinische Wochenschrift|July 2, 2002
Medullary thyroid carcinomas in cell culture--models for future therapiesRoswitha Pfragner, Gerhard H Wirnsberger, Elisabeth Ingolic, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapyM E Scheulen, K Bremer, N Niederle, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1982
[Esophageal carcinoma: a one-time procedure with stomach transposition as a therapeutic concept (author's transl)]J M Funovics, R Roka, B Niederle, et al.
Pageof 49

Showing results (131-140 of 490) with videos related to

Sort By:
Pageof 49
Gland Surgery|July 17, 2025
<i>RET</i> Y791F in MEN2: a variant presumed non-pathogenic, yet lacking conclusive evidence of insignificanceTeresa Binter, Martin Bruno Niederle, Melisa Arikan, et al.
International Journal of Cell Cloning|September 1, 1992
Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemiaU B Wandl, N Niederle, M Kranzhoff, et al.
Deutsche Medizinische Wochenschrift (1946)|December 25, 1981
[Individualized interval shortening in the chemotherapeutic induction treatment of solid tumors (author's transl)]S Seeber, M Higi, N Niederle, et al.
Wiener Klinische Wochenschrift|November 3, 2004
[Imaging of tumours of the adrenal gland]Gertraud Heinz-Peer, Brigitte Happel, Gerhard Prager, et al.
Wiener Klinische Wochenschrift|January 1, 1993
[Diabetes mellitus and carbohydrate metabolism in primary hyperparathyroidism]A Kautzky-Willer, B Niederle, G Schernthaner, et al.
Klinische Wochenschrift|July 15, 1987
[Detection of nephrotoxicity of human alpha 2b interferon with special reference to the analysis of urine enzymes in patients with chronic myeloid leukemia]E Kurschel, U Metz-Kurschel, W Hofmann, et al.
Cancers|February 10, 2024
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?Teresa Binter, Sabina Baumgartner-Parzer, Marie Helene Schernthaner-Reiter, et al.
Wiener Klinische Wochenschrift|July 2, 2002
Medullary thyroid carcinomas in cell culture--models for future therapiesRoswitha Pfragner, Gerhard H Wirnsberger, Elisabeth Ingolic, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapyM E Scheulen, K Bremer, N Niederle, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1982
[Esophageal carcinoma: a one-time procedure with stomach transposition as a therapeutic concept (author's transl)]J M Funovics, R Roka, B Niederle, et al.
Pageof 49